Moreover, we also employed a panel of commercially available antibodies to identify Aβ and pTau, and the inflammasome proteins, NLRP‐1, NLRP‐3, and caspase‐1 in postmortem human brains with and without intermediate AD neuropathological changes. The gene discussed is NLRP3; the disease is Alzheimer disease.